Building Better GLP-1 Care at Scale w/ Dr. Myra Ahmad, CEO & Founder, Mochi Health
CareTalk: Healthcare. Unfiltered.
Evolution of GLP-1 indications and injectables
Myra explains how drug makers and research are expanding GLP-1 use for obesity, PCOS, fertility, and more.
Demand for GLP-1 medications has exploded in recent years. What started as a diabetes treatment has quickly become one of the most talked-about forces in healthcare, reshaping how we think about obesity, metabolic disease, access, affordability, and long-term care.
But with rapid growth comes confusion: questions about safety, cost, supply constraints, and whether the current system is actually capable of supporting patients for the long haul.
Dr. Myra Ahmad, Founder and CEO of Mochi Health joins CareTalk host David E. Williams to discuss what’s getting lost in the GLP-1 conversation, why most care models are not built for long-term obesity treatment, and how Mochi is approaching physician-guided metabolic care at scale.
🎙️⚕️ABOUT MYRA AHMAD
Founder and CEO of Mochi Health, Myra Ahmad, launched Mochi in 2022 to address the overwhelming inaccessibility of quality obesity treatment but has since expanded access to evidence-based care and empowered patients to make customized treatment plans with their provider using any of Mochi's 150+ offerings. With this, Dr. Ahmad is pushing the limits of health tech and accessibility, all while fighting back against the established healthcare system who aim to keep their monopoly on healthcare.
Under her leadership, Mochi has grown into an expansive network of over 400 affiliated healthcare providers and is building the future of tech-enabled care. Mochi's comprehensive platform enables seamless communication between pharmacies and providers, features a proprietary electronic medical record system, and incorporates AI transcription tools to reduce physicians' administrative workload in favor of a greater focus on patient-centric care.
Dr. Ahmad also received her MD from the University of Washington School of Medicine and has held research positions at the MIT Koch Institute for Integrative Cancer Research, UCSF Medical Center, and University of California, San Francisco. She now leads a corporate team of over 60 employees and is growing out of Mochi's headquarters in San Francisco.
🎙️⚕️ABOUT MOCHI HEALTH
Mochi Health is setting the new standard for personalized medicine, combining increased access to life-changing medication, physician-guided telemedicine care, and an integrated approach to treatment. Patients can choose between medication and nutrition-based weight loss treatments, personalized by their team of board-certified doctors and registered dietitians. Mochi Health subscriptions offer evidence-based, safe, accessible, and effective treatment options, designed to support patients’ entire health journey.
🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (Chairman, UConn Health) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.
GET IN TOUCH
Follow CareTalk on LinkedIn
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
Subscribe to the CareTalk Newsletter
⚙️CareTalk: Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.
The AI-powered Podcast Player
